Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

540 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.
Duwe L, Munoz-Garrido P, Lewinska M, Lafuente-Barquero J, Satriano L, Høgdall D, Taranta A, Nielsen BS, Ghazal A, Matter MS, Banales JM, Aldana BI, Gao YT, Marquardt JU, Roberts LR, Oliveira RC, Koshiol J, O'Rourke CJ, Andersen JB. Duwe L, et al. Among authors: roberts lr. J Hepatol. 2023 Feb;78(2):364-375. doi: 10.1016/j.jhep.2022.10.012. Epub 2022 Oct 28. J Hepatol. 2023. PMID: 36848245 Free article.
Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV.
Kim K, Zheng Y, Joyce BT, Nannini DR, Wang J, Qu Y, Hawkins CA, Okeke E, Lesi OA, Roberts LR, Gursel DB, Abdulkareem FB, Akanmu AS, Duguru MJ, Davwar P, Nyam DP, Adisa RA, Imade G, Wei JJ, Kocherginsky M, Kim KY, Adeyemo WL, Odeghe E, Wehbe FH, Achenbach C, Sagay A, Ogunsola F, Murphy RL, Hou L. Kim K, et al. Among authors: roberts lr. Hepatol Int. 2024 Dec 20. doi: 10.1007/s12072-024-10768-1. Online ahead of print. Hepatol Int. 2024. PMID: 39704909
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade.
Tesfay MZ, Zhang Y, Ferdous KU, Taylor MA, Cios A, Shelton RS, Simoes CC, Watters CR, Barro O, Elliott NM, Mustafa B, Chamcheu JC, Graham AL, Washam CL, Alkam D, Gies A, Byrum SD, Giorgakis E, Post SR, Kelly T, Ying J, Moaven O, Chabu CY, Fernandez-Zapico ME, Duda DG, Roberts LR, Govindarajan R, Borad MJ, Cannon MJ, Basnakian AG, Nagalo BM. Tesfay MZ, et al. Among authors: roberts lr. Mol Ther Oncol. 2024 Nov 26;32(4):200913. doi: 10.1016/j.omton.2024.200913. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39758249 Free PMC article.
Surveillance for Hepatocellular Carcinoma.
Roberts LR. Roberts LR. Clin Liver Dis. 2025 Feb;29(1):17-31. doi: 10.1016/j.cld.2024.09.001. Epub 2024 Oct 28. Clin Liver Dis. 2025. PMID: 39608955 Review.
Genome-wide DNA methylation markers associated with metabolic liver cancer.
Antwi SO, Siaw ADJ, Armasu SM, Frank JA, Yan IK, Ahmed FY, Izquierdo-Sanchez L, Boix L, Rojasti A, Banales JM, Reig M, Stål P, Romero Gómez M, Wangensteen KJ, Singal AG, Roberts LR, Patel T. Antwi SO, et al. Among authors: roberts lr. medRxiv [Preprint]. 2024 Nov 15:2024.11.15.24317378. doi: 10.1101/2024.11.15.24317378. medRxiv. 2024. PMID: 39606355 Free PMC article. Preprint.
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis.
Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y. Fujiwara N, et al. Among authors: roberts lr. Gastroenterology. 2024 Nov 8:S0016-5085(24)05660-9. doi: 10.1053/j.gastro.2024.10.035. Online ahead of print. Gastroenterology. 2024. PMID: 39521255 Free article.
540 results